CA3070663A1 - Treatment of non-inflammatory lesions - Google Patents

Treatment of non-inflammatory lesions Download PDF

Info

Publication number
CA3070663A1
CA3070663A1 CA3070663A CA3070663A CA3070663A1 CA 3070663 A1 CA3070663 A1 CA 3070663A1 CA 3070663 A CA3070663 A CA 3070663A CA 3070663 A CA3070663 A CA 3070663A CA 3070663 A1 CA3070663 A1 CA 3070663A1
Authority
CA
Canada
Prior art keywords
methyl
effective amount
therapeutically effective
pharmaceutically acceptable
weeks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3070663A
Other languages
English (en)
French (fr)
Inventor
David Berk
Alexandre Kaoukhov
Vilma SNIUKIENE
Carsten Schmitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall LLC
Original Assignee
Almirall LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall LLC filed Critical Almirall LLC
Publication of CA3070663A1 publication Critical patent/CA3070663A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3070663A 2017-07-21 2018-07-20 Treatment of non-inflammatory lesions Pending CA3070663A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762535572P 2017-07-21 2017-07-21
US62/535,572 2017-07-21
PCT/IB2018/000938 WO2019016609A1 (en) 2017-07-21 2018-07-20 TREATMENT OF NON-INFLAMMATORY LESIONS

Publications (1)

Publication Number Publication Date
CA3070663A1 true CA3070663A1 (en) 2019-01-24

Family

ID=63713912

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3070663A Pending CA3070663A1 (en) 2017-07-21 2018-07-20 Treatment of non-inflammatory lesions

Country Status (13)

Country Link
US (1) US20200222432A1 (https=)
EP (1) EP3654988B1 (https=)
JP (1) JP2020527607A (https=)
KR (1) KR102662461B1 (https=)
CN (1) CN111343991A (https=)
AU (1) AU2018303807B2 (https=)
BR (1) BR112020000968A2 (https=)
CA (1) CA3070663A1 (https=)
ES (1) ES2962380T3 (https=)
IL (1) IL272124A (https=)
MA (1) MA49641A (https=)
MX (1) MX2020000816A (https=)
WO (1) WO2019016609A1 (https=)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990331A (en) 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
US2980584A (en) 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US3062717A (en) 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3165531A (en) 1962-03-08 1965-01-12 Pfizer & Co C 13-substituted-6-deoxytetracyclines and process utilizing the same
US3454697A (en) 1965-06-08 1969-07-08 American Cyanamid Co Tetracycline antibiotic compositions for oral use
NL6607516A (https=) 1966-05-31 1967-12-01
DE1767891C3 (de) 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
DE2442829A1 (de) 1974-09-06 1976-03-18 Merck Patent Gmbh Tetracyclische verbindungen und verfahren zu ihrer herstellung
US4018889A (en) 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
US4126680A (en) 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
EP1383508B1 (en) * 2001-04-05 2006-06-21 Collagenex Pharmaceuticals, Inc. Doxycycline for the treatment of acne
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
CA2892739A1 (en) * 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
WO2008079339A2 (en) 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
CA2724412A1 (en) * 2008-05-21 2009-11-26 Galderma Research & Development Maintenance therapy regimen for treating acne
CN102056481A (zh) * 2008-06-05 2011-05-11 陶氏制药科学公司 包含低浓度的在水和水混溶性有机溶剂中的悬浮液形式的过氧苯甲酰的局部药物制剂
JP2013500984A (ja) * 2009-07-30 2013-01-10 アラーガン、インコーポレイテッド ダプソンとアダパレンの組み合わせ
US20140121188A1 (en) * 2009-10-02 2014-05-01 Foamix Ltd. Compositions for the improved treatment of acne and related disorders
US9255068B2 (en) * 2011-05-12 2016-02-09 Warner Chilcott Company, Llc Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same
IL225246A0 (en) * 2012-03-15 2013-06-27 Meir Eini Methods for speeding up the restoration of skin normality and for treatment of impetigo
GB201615693D0 (en) * 2016-09-15 2016-11-02 Combinatorx Infection Ltd Combinations

Also Published As

Publication number Publication date
AU2018303807B2 (en) 2023-08-24
IL272124A (en) 2020-03-31
WO2019016609A1 (en) 2019-01-24
KR20200031126A (ko) 2020-03-23
EP3654988A1 (en) 2020-05-27
BR112020000968A2 (pt) 2020-07-14
ES2962380T3 (es) 2024-03-18
CN111343991A (zh) 2020-06-26
AU2018303807A1 (en) 2020-02-13
MA49641A (fr) 2021-06-02
US20200222432A1 (en) 2020-07-16
JP2020527607A (ja) 2020-09-10
MX2020000816A (es) 2020-08-17
KR102662461B1 (ko) 2024-04-30
EP3654988B1 (en) 2023-09-06

Similar Documents

Publication Publication Date Title
JP5744976B2 (ja) にきびの治療方法発明の分野
US20030082120A1 (en) Method for reducing systemic effects of aging, effects of aging on the skin, and incidence of skin damage from sun exposure using antibiotics of the tetracycline family
ES2985493T3 (es) Composición farmacéutica para administración oral que comprende sales cristalinas de amida del ácido (4S,4aS,5aR,12aS)-4-dimetilamino-3,10,12,12a-tetrahidroxi-7-[(metoxi(metil)amino)-metil]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahidro-naftacen-2-carboxílico
US20050239723A1 (en) Compositions and methods useful for treatment of acne
AU2018303807B2 (en) Treatment of non-inflammatory lesions
HK40019815B (en) Sarecycline for the treatment of non-inflammatory acne lesions
HK40019815A (en) Sarecycline for the treatment of non-inflammatory acne lesions
CN110446505A (zh) 用于治疗皮肤病的联合疗法
CN112770765B (zh) 用于预防和/或治疗泌尿生殖器粘膜的组合物
JP2015081244A (ja) ニキビ治療用医薬組成物
JP2024041865A (ja) パ－キンソン病治療用の新規高透過薬物及びその組成物
CN1852729A (zh) 疮疱丙酸杆菌的抗菌剂
Sharma et al. Efficacy of Azithromycin pulse therapy in acne vulgaris treatment: A hospital based study
IL302978A (en) Local administration of 2-(diethylamino)ethyl 2-(4-isobutylphenyl)propionate for the treatment of diseases
RU2242988C1 (ru) Способ лечения и профилактики лучевых повреждений нижних отделов толстой кишки
JP2002265354A (ja) 抗ピロリ菌剤組成物
Weber et al. (312/776): Efficacy and safety of tapentadol HCl in patients with pain after bunionectomy
CN110691591A (zh) 用于在治疗寻常痤疮中使用的希波酚
JP2011121939A (ja) 消化器疾患治療剤
JP2020527607A5 (https=)
US20090215889A1 (en) Novel Use of Zinc Gluconate for Treating Hydradenitis Suppurativa
Alkhamesi et al. (312/756): Aerosolized bupivacaine reduces post-laparoscopic pain: A randomized controlled double blinded clinical trial
HK40011827A (en) Combination therapy for treatment of skin diseases
Backonja et al. (312/745): Gabapentin exposure and pain reduction in patients with postherpetic neuralgia: analysis of a phase 2a randomized, double-blind, placebo controlled study of neurontin and XP13512
EP1370263A1 (en) Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20230503

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

B12 Application deemed to be withdrawn, abandoned or lapsed

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION

Effective date: 20241021

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260108